Showing results (481-490 of 6,497) with videos related to
Sort By:
Pageof 650
Human Vaccines & Immunotherapeutics|May 21, 2020
Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell cultureMikhail F Vorovitch, Karina G Grishina, Viktor P Volok, et al.Human Vaccines & Immunotherapeutics|May 21, 2020
Pneumococcal vaccination coverage in France by general practitioners in adults with a high risk of pneumococcal diseaseAude Kopp, Olivier Mangin, Laurène Gantzer, et al.Human Vaccines & Immunotherapeutics|May 21, 2020
Participation in an action research project on vaccine services for children: relationship with vaccine delaysMariejka Beauregard, Nicholas Brousseau, Manale Ouakki, et al.Human Vaccines & Immunotherapeutics|May 14, 2020
Synchrony in serum antibody response to conserved proteins of Moraxella catarrhalis in young childrenDabin Ren, Peter Bajorski, Timothy F Murphy, et al.Human Vaccines & Immunotherapeutics|June 18, 2015
Immunological persistence of a seasonal influenza vaccine in people more than 3 years oldYunhua Bai, Nianmin Shi, Qiang Lu, et al.Human Vaccines & Immunotherapeutics|June 19, 2015
A novel recombinant vaccine protecting mice against abrin intoxicationJunhong Wang, Shan Gao, Wenwen Xin, et al.Human Vaccines & Immunotherapeutics|June 20, 2015
Investigation into alternative testing methodologies for characterization of influenza virus vaccineTracy Tay, Catherine Agius, Ross Hamilton, et al.Human Vaccines & Immunotherapeutics|June 20, 2015
Influence of the microbiome on response to vaccinationAmanda M JamiesonHuman Vaccines & Immunotherapeutics|June 20, 2015
A microarray MEMS device for biolistic delivery of vaccine and drug powdersFatemeh Nazly Pirmoradi, Ashish V Pattekar, Felicia Linn, et al.Human Vaccines & Immunotherapeutics|June 20, 2015
Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United KingdomThierry P Van Effelterre, Cosmina Hogea, Sylvia M TaylorPageof 650